172 related articles for article (PubMed ID: 18039381)
21. Acute study of clinical effectiveness of nesiritide in decompensated heart failure: nesiritide redux.
Pleister AP; Baliga RR; Haas GJ
Curr Heart Fail Rep; 2011 Sep; 8(3):226-32. PubMed ID: 21695395
[TBL] [Abstract][Full Text] [Related]
22. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Aronson D; Burger AJ
Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
[TBL] [Abstract][Full Text] [Related]
23. Nesiritide in infants and children with congestive heart failure.
Mahle WT; Cuadrado AR; Kirshbom PM; Kanter KR; Simsic JM
Pediatr Crit Care Med; 2005 Sep; 6(5):543-6. PubMed ID: 16148814
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
[TBL] [Abstract][Full Text] [Related]
25. Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials.
Wong YW; Mentz RJ; Felker GM; Ezekowitz J; Pieper K; Heizer G; Hasselblad V; Metra M; O'Connor CM; Armstrong PW; Starling RC; Hernandez AF
Eur J Heart Fail; 2016 Jun; 18(6):684-92. PubMed ID: 26817735
[TBL] [Abstract][Full Text] [Related]
26. Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure.
Scroggins N; Edwards M; Delgado R
Congest Heart Fail; 2005; 11(6):311-4. PubMed ID: 16330906
[TBL] [Abstract][Full Text] [Related]
27. Nesiritide: harmful or harmless?
Dorsch MP; Rodgers JE
Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
[TBL] [Abstract][Full Text] [Related]
28. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
[TBL] [Abstract][Full Text] [Related]
29. Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
Wang XC; Zhu DM; Shan YX
Am J Cardiovasc Drugs; 2015 Dec; 15(6):429-37. PubMed ID: 26123415
[TBL] [Abstract][Full Text] [Related]
30. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769
[TBL] [Abstract][Full Text] [Related]
31. Nesiritide for the treatment of decompensated heart failure.
Wylie JV; Tsao L
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
[TBL] [Abstract][Full Text] [Related]
32. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
Noviasky JA
Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
[TBL] [Abstract][Full Text] [Related]
33. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
Silver MA; Horton DP; Ghali JK; Elkayam U
J Am Coll Cardiol; 2002 Mar; 39(5):798-803. PubMed ID: 11869844
[TBL] [Abstract][Full Text] [Related]
34. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
Arora S; Clarke K; Srinivasan V; Gradman A
QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
[TBL] [Abstract][Full Text] [Related]
35. Effect of nesiritide on length of hospital stay in patients with decompensated heart failure.
Chang R; Elatre WA; Heywood JT
J Cardiovasc Pharmacol Ther; 2004 Sep; 9(3):173-7. PubMed ID: 15378137
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.
Hiestand B; Abraham WT
Curr Cardiol Rep; 2007 May; 9(3):182-6. PubMed ID: 17470330
[TBL] [Abstract][Full Text] [Related]
37. Impact of nesiritide on health care resource utilization and complications in patients with decompensated heart failure.
Lenz TL; Foral PA; Malesker MA; Hunter CB; Hilleman DE
Pharmacotherapy; 2004 Sep; 24(9):1137-46. PubMed ID: 15460174
[TBL] [Abstract][Full Text] [Related]
38. Critical review and recommendations for nesiritide use in the emergency department.
Collins SP; Hinckley WR; Storrow AB
J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery.
Beaver TM; Winterstein AG; Shuster JJ; Gerhard T; Martin T; Alexander JA; Johnson RJ; Ejaz A; Hartzema AG
Clin Cardiol; 2006 Jan; 29(1):18-24. PubMed ID: 16477773
[TBL] [Abstract][Full Text] [Related]
40. Impact of acute serum creatinine elevation in patients treated with nesiritide.
Elkayam U; Janmohamed M; Hatamizadeh P; Heywood JT; Wei LJ; Mills RM
Clin Cardiol; 2009 Apr; 32(4):215-9. PubMed ID: 19353723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
